相关实验视频

Updated: Jun 28, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

在治疗甲状腺功能障碍时Zhizi Qinggan的作用:系统性审查和元分析

Min Zhang¹, Jiashuai Chu², Chang Xiu²

¹Discipline Inspection Commission Office, The Third Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.

|September 17, 2025

概括

与甲基马片结合的齐齐清干显著改善了甲状腺功能障碍治疗的结果,包括甲状腺激素水平和临床疗效,与单独的西方医学相比. 建议进行进一步的大规模试验,以巩固证据.

科学领域:

内分泌学在内分泌学.
综合医学是一个整体的医学.
药理学药理学是指药理学的学科.

背景情况:

甲状腺功能障碍是一种常见的内分泌疾病,需要有效的治疗.
传统中医 (TCM) 提供潜在的补充疗法.
齐齐清干是一种用于甲状腺功能增强症的TCM配方.

研究的目的:

系统地审查和分析Zhizi Qinggan Decoction与甲基马片治疗甲状腺功能障碍的疗效.
为这种联合治疗的临床应用提供基于证据的支持.

主要方法:

系统搜索多个中国和英语数据库,直到2024年8月.
包括Zhizi Qinggan甲状腺功能障碍治疗中药的随机对照试验 (RCT).
使用Stata 14.0的元分析来评估甲状腺激素水平,临床有效性和TCM综合征得分.

主要成果:

分析了16个涉及1320名患者的RCT.
组合疗法显著改善了自由三甲状腺素,自由甲状腺素和甲状腺刺激激素水平.
结合治疗观察到改善的临床疗效和降低的TCM综合征得分.
组合疗法也显示了减少不良反应的显著改善.

结论:

齐齐清干与甲基马片结合,显示出对甲状腺功能增强症的良好临床治疗结果.
这种组合疗法为治疗甲状腺功能增强症提供了一种有前途的方法.
需要进一步的大规模,严格的RCT来加强广泛临床采用的证据基础.

关键词:

齐齐清根的蒸清根的蒸甲状腺功能过强症甲状腺功能过强症这是一个元分析.

更多相关视频

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

相关概念视频

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...